Vimarsana
Biggest News Aggregation in the World

Page 22 - Special Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Special Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Special Access Program Today - Breaking & Trending Today

PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA - Vimarsana News

PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA

This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia, May 16, 2023 -- PharmAla Biotech Holdings... | May 16, 2023

US Air Force's Next-Gen Tactical Missile Is Set To Change Air Combat - Vimarsana News

US Air Force's Next-Gen Tactical Missile Is Set To Change Air Combat

The US Air Force's AIM-260 JATM will enter production this year and is expected to give the service a significant advantage in air combat.

Source: sofrep.com
Kemp Signs Bill Allowing Removal of Local Prosecutors in GA - Vimarsana News

Kemp Signs Bill Allowing Removal of Local Prosecutors in GA

Georgia Governor Brian Kemp has signed a bill establishing the Prosecuting Attorneys Qualifications Commission (PACQ), which has the power to remove local prosecutors who

Source: drudge.com
Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: ... - Vimarsana News

Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: ...

Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: ...

Core One Labs Inc.: Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy - Vimarsana News

Core One Labs Inc.: Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its wholly-owned subsidiaries